Pharmaceuticals bioequivalence

WA Ritschel, DD Denson. Influence of disease on bioavailability. In PG Welling, FLS Tse, SV Dighe, eds. Pharmaceutical Bioequivalence. New York Marcel Dekker, 1991, pp. 67-115. 

Pharmaceutical Bioequivalence, edited by Peter G. Welling, Francis L. S. Tse, and Shrikant V. Dinghe... 

Dressman JB and Yamada K (1991) Animal Models for Oral Absorption. In PG Welling, FLS Tse, SV Dinghe (Eds.), Pharmaceutical Bioequivalence, VI48. New York, Dekker, pp 727-739. 

Dressman JB, Yamada K. 1991. Animal models for oral drug absorption. In Pharmaceutical Bioequivalence, ed. P Welling, FL Welling, pp. 235-66. New York Dekker... 

Dighe SV, Adams WP. Bioequivalence A United States regulatory perspective. In Welling PG, Tse FLS, Dighe SV, eds. Pharmaceutical Bioequivalence, 1st edn. New York Marcel Dekker, 1991 347 80. 

Reprinted from Animal models for oral drug absorption, by J. B. Dressman and K. Yamada in Pharmaceutical Bioequivalence, ... 

Preclinical Dmg Disposition A Laboratory Handbook, Francis L. S. Tse and James J. Jaffe 47. HPLC in the Pharmaceutical Industry, edited by Godwin W Fong and Stanley K. Lam 48. Pharmaceutical Bioequivalence, edited by Peter G. Welling, Francis L. S. Tse, andShrikant V. Dinghe... 

---